Forte Biosciences, Inc. Share Price & Technical Analysis
FBRX · $17.00 (-6.49%)
Healthcare / Biotechnology
$17.00
-6.49%
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dalla…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-12% return in Jun, 13% avg return in past 3 year Jun month.
-44% return in 2026, 124% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 8% | 4% | -13% | -2% | -29% | -12% | – | – | – | – | – | – | -44% |
| 25 | -33% | -43% | -13% | -3% | 25% | 47% | -23% | 8% | 39% | -12% | 44% | 44% | 80% |
| 24 | -26% | 13% | 1% | 5% | -16% | -11% | 5% | -42% | -29% | -20% | 393% | 3% | 276% |
| 23 | 0% | 0% | -1% | 7% | -5% | 3% | -3% | -18% | -20% | -24% | -2% | 78% | 16% |
| 22 | -21% | -26% | 17% | -20% | 19% | -2% | -3% | 7% | -18% | 2% | -7% | 3% | -49% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$365.96M
P/E ratio
—
52W high
$35.80
52W low
$9.10
Volume
3,21,827
Beta
3.00
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Forte Biosciences, Inc. share price today?
- Forte Biosciences, Inc. (FBRX) last traded around $17.00 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does FBRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for FBRX. Download the app for real-time alerts.
- How can I analyze Forte Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.